Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q3 2024 · 10-Q
Revenue—
Net Income-$4.85M-$4.85MN/M vs Q3 2023 EPS Diluted-$3.76-$3.76N/M vs Q3 2023 Operating Income-$4,961,467N/M Operating Cash Flowderived-$4,055,469N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,058,348N/M ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end